Cryogenic OGS Reports No Fund Utilization Deviation

Cryogenic OGS Limited filed a regulatory statement with BSE confirming no deviation in IPO fund utilization for the half-year ended March 31, 2026.
The company raised ₹17.76 crores through an initial public offering on July 10, 2025, for working capital and general corporate purposes.
Audit committee and board reviewed the statement on April 30, 2026, with no comments from auditors or the committee.
Funds were utilized as per original objects: ₹240.12 lakhs for working capital, ₹284.31 lakhs for general purpose, and ₹228.29 lakhs for issue expenses.